Victor Conte, the founder of BALCO, the California lab at the center of a performance-enhancing drug scandal involving high-profile athletes like Barry Bonds and Marion Jones, died on Monday, ...

President Donald Trump’s vow to wage the biggest domestic deportation program in American history – expelling a million ...

The AI Portfolio also ended in negative territory, falling 0.8%. Total portfolio returns now stand at 6% since inception. The top gaining stocks were Twilio (+17.7%), Amazon (+8.6%) and Marvell ...

Isekai (“another world”) is a genre notorious for junk, simply because of the sheer influx of shows of the kind that ...

As the first-ever National Games co-hosted by Guangdong province and the Hong Kong and Macao special administrative regions ...

For New Yorkers, Woodbury Common represents a retail escape valve – a place where the pressure of city prices eases just enough to make luxury attainable. The journey from Manhattan takes about an ...

BARCELONA, Spain — An experimental drug that takes a novel approach to protecting injured brain cells has shown promising results in an early Phase 2 trial of patients with acute ischemic stroke (AIS) ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. The trial results ...

The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by ...

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients whose prostate cancer had returned, a large international clinical trial has ...

Once a drug target is identified, it often takes decades until a chemical compound is developed that can hit the bullseye and ...

Dianthus Therapeutics and Boehringer Ingelheim headlined the latest round of licensing deals featuring Chinese biotechs. Fierce's deep dive into the dispute between Novo Nordisk and KBP Biosciences ...